Evaluation of a complex integrated, cross-sectoral psycho-oncological care program (isPO): a mixed-methods study protocol

被引:19
|
作者
Jenniches, Imke [1 ]
Lemmen, Clarissa [2 ]
Cwik, Jan Christopher [3 ]
Kusch, Michael [4 ]
Labouvie, Hildegard [4 ]
Scholten, Nadine [1 ]
Gerlach, Alexander [5 ]
Stock, Stephanie [2 ]
Samel, Christina [6 ]
Hagemeier, Anna [6 ]
Hellmich, Martin [6 ]
Haas, Peter [7 ]
Hallek, Michael [4 ]
Pfaff, Holger [1 ]
Dresen, Antje [1 ]
机构
[1] Univ Cologne, IMVR Inst Med Sociol, Hlth Serv Res & Rehabil Sci IMVR, Cologne, Germany
[2] Univ Hosp Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany
[3] Univ Cologne, Clin Psychol & Psychotherapy, Cologne, Germany
[4] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany
[5] Univ Cologne, Dept Psychol, Cologne, Germany
[6] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany
[7] Univ Appl Sci & Arts Dortmund, Dept Comp Sci Med Informat, Dortmund, Germany
来源
BMJ OPEN | 2020年 / 10卷 / 03期
关键词
HEALTH-SERVICES RESEARCH; QUALITY-OF-LIFE; CANCER-PATIENTS; ANXIETY; INTERVENTIONS; DEPRESSION; DISTRESS; PREVALENCE;
D O I
10.1136/bmjopen-2019-034141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction International standards of care require the complete integration of psycho-oncological care into biomedical cancer treatment. The structured integrated, cross-sectoral psycho-oncological programme 'isPO' is aiming to ensure a provision of care in inpatient and outpatient settings according to a stepped-care approach. Up to now, psycho-oncological care is missing regulated and standardised processes to demonstrate the effectiveness. This study protocol describes the process and outcome evaluation that is conducted, along with the isPO study. The programme evaluation is aiming to proof effectiveness, explain potential discrepancies between expected and observed outcomes. Additionally, provide insight into the implementation process, as well as contextual factors that might promote or inhibit the dissemination and implementation of the stepped care programme will be gained. In addition to these measures, a cost-consequence analysis will provide further evidence aimed at integrating psycho-oncological care into primary healthcare. Methods and analysis The evaluation concept is based on a tripartite strategy consisting of a prospective, formative and summative evaluation. To capture all determinants, a concurrent mixed-method design is applied comprising qualitative (interviews and focus groups) and quantitative (standardised questionnaires) surveys of patients and healthcare providers. In addition, analysis of the psycho-oncological care data (isPO care data) and statutory health insurance claims data will be conducted. Primary and secondary data will complement one another (data linkage) to obtain a more comprehensive picture of the effectiveness and implementation of the complex intervention within the isPO study. Ethics and dissemination The study has been approved by the ethics committee of the Medical Faculty of the University of Cologne. For all collected data, the relevant national and European data protection regulations will be considered. All personal identifiers (eg, name, date of birth) will be pseudonymised. Dissemination strategies include annual reports as well as quality workshops for the organisations, the presentation of results in publications and on conferences, and public relations.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [1] Integration of Cross-Sectoral Psycho-Oncological Care into Inpatient and Outpatient Cancer Therapy
    Krebs, Steffen
    Benner, Jennifer
    Matyschik, Lukas
    Osborne, Karin
    Wolf, Juergen
    Kusch, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 147 - 147
  • [2] Conducting a prospective evaluation of the development of a complex psycho-oncological care programme (isPO) in Germany
    Sandra Salm
    Natalia Cecon
    Imke Jenniches
    Holger Pfaff
    Nadine Scholten
    Antje Dresen
    Theresia Krieger
    BMC Health Services Research, 22
  • [3] Integrated, cross-sectoral Psycho-Oncology (isPO): Chances and challanges of external process evaluation
    Dresen, A. Dr.
    Scholten, N.
    Pfaff, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 140 - 140
  • [4] Evaluation of the access process to psycho-oncology care: results from the German integrated, cross-sectoral psycho-oncology programme (isPO)
    Klein, Anne
    Schiewer, Vera
    Labouvie, Hildegard
    Kusch, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 210 - 210
  • [5] Integrating one-to-one peer support into psycho-oncological care in Germany: multi-perspective, mixed-methods evaluation of the isPO onco-guide service
    Sandra Salm
    Stefanie Houwaart
    Natalia Cecon-Stabel
    Antje Dresen
    Holger Pfaff
    Nadine Scholten
    Theresia Krieger
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10399 - 10422
  • [6] Integrating one-to-one peer support into psycho-oncological care in Germany: multi-perspective, mixed-methods evaluation of the isPO onco-guide service
    Salm, Sandra
    Houwaart, Stefanie
    Cecon-Stabel, Natalia
    Dresen, Antje
    Pfaff, Holger
    Scholten, Nadine
    Krieger, Theresia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10399 - 10422
  • [7] Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany
    Kusch, Michael
    Labouvie, Hildegard
    Schiewer, Vera
    Talalaev, Natalie
    Cwik, Jan C.
    Bussmann, Sonja
    Vaganian, Lusine
    Gerlach, Alexander L.
    Dresen, Antje
    Cecon, Natalia
    Salm, Sandra
    Krieger, Theresia
    Pfaff, Holger
    Lemmen, Clarissa
    Derendorf, Lisa
    Stock, Stephanie
    Samel, Christina
    Hagemeier, Anna
    Hellmich, Martin
    Leicher, Bernd
    Hueltenschmidt, Gregor
    Swoboda, Jessica
    Haas, Peter
    Arning, Anna
    Goettel, Andrea
    Schwickerath, Kathrin
    Graeven, Ullrich
    Houwaart, Stefanie
    Kerek-Bodden, Hedy
    Krebs, Steffen
    Muth, Christiana
    Hecker, Christina
    Reiser, Marcel
    Mauch, Cornelia
    Benner, Jennifer
    Schmidt, Gerdamarie
    Karlowsky, Christiane
    Vimalanandan, Gisela
    Matyschik, Lukas
    Galonska, Lars
    Francke, Annette
    Osborne, Karin
    Nestle, Ursula
    Baeumer, Markus
    Schmitz, Kordula
    Wolf, Juergen
    Hallek, Michael
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [8] Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany
    Michael Kusch
    Hildegard Labouvie
    Vera Schiewer
    Natalie Talalaev
    Jan C. Cwik
    Sonja Bussmann
    Lusine Vaganian
    Alexander L. Gerlach
    Antje Dresen
    Natalia Cecon
    Sandra Salm
    Theresia Krieger
    Holger Pfaff
    Clarissa Lemmen
    Lisa Derendorf
    Stephanie Stock
    Christina Samel
    Anna Hagemeier
    Martin Hellmich
    Bernd Leicher
    Gregor Hültenschmidt
    Jessica Swoboda
    Peter Haas
    Anna Arning
    Andrea Göttel
    Kathrin Schwickerath
    Ullrich Graeven
    Stefanie Houwaart
    Hedy Kerek-Bodden
    Steffen Krebs
    Christiana Muth
    Christina Hecker
    Marcel Reiser
    Cornelia Mauch
    Jennifer Benner
    Gerdamarie Schmidt
    Christiane Karlowsky
    Gisela Vimalanandan
    Lukas Matyschik
    Lars Galonska
    Annette Francke
    Karin Osborne
    Ursula Nestle
    Markus Bäumer
    Kordula Schmitz
    Jürgen Wolf
    Michael Hallek
    BMC Health Services Research, 22
  • [9] The components of the new form of care isPO: Result of the innovation fund project on integrated, cross-sectoral psycho-oncology
    Labouvie, Hildegard
    Schiewer, Vera
    Talalaev, Natalie
    Klein, Anne
    Haas, Peter
    Kusch, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 208 - 208
  • [10] The impact of COVID-19 on the interpretation of psycho-oncological support trial results: a quasi-experimental approach using the data from the new form of care “Integrated cross-sectoral psycho-oncology (nFC-isPO)”
    Anna Hagemeier
    Anne Adams
    Theresia Krieger
    Sandra Salm
    Natalia Cecon-Stabel
    Antje Dresen
    Martin Hellmich
    BMC Health Services Research, 23